BRCA1 mutations in a population-based sample of young women with breast cancer

被引:274
|
作者
Langston, AA
Malone, KE
Thompson, JD
Daling, JR
Ostrander, EA
机构
[1] FRED HUTCHINSON CANC RES CTR, DIV CLIN RES, SEATTLE, WA 98104 USA
[2] FRED HUTCHINSON CANC RES CTR, DIV PUBL HLTH SCI, SEATTLE, WA 98104 USA
[3] UNIV WASHINGTON, DEPT EPIDEMIOL, SEATTLE, WA 98195 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1996年 / 334卷 / 03期
关键词
D O I
10.1056/NEJM199601183340301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Inherited mutations in the BRCA1 gene are associated with a high risk of breast and ovarian cancer in some families, However, little is known about the contribution of BRCA1 mutations to breast cancer in the general population, We analyzed DNA samples from women enrolled in a population-based study of early-onset breast cancer to assess the spectrum and frequency of germ-line BRCA1 mutations in young women with breast cancer. Methods. We studied 80 women in whom breast cancer was diagnosed before the age of 35, and who were not selected on the basis of family history. Genomic DNA was studied for BRCA1 mutations by analysis involving singlestrand conformation polymorphisms and with allele-specific assays, Alterations were defined by DNA sequencing. Results. Germ-line BRCA1 mutations were identified in 6 of the 80 women, Four additional rare sequence variants of unknown functional importance were also identified, Two of the mutations and three of the rare sequence variants were found among the 39 women who reported no family history of breast or ovarian cancer. None of the mutations and only one of the rare variants was identified in a reference population of 73 unrelated subjects. Conclusions. Alterations in BRCA1 were identified in approximately 10 percent of this cohort of young women with breast cancer, The risk of harboring a mutation was not limited to women with family histories of breast or ovarian cancer, These results represent a minimal estimate of the frequency of BRCA1 mutations in this population. Comprehensive methods of identifying BRCA1 mutations and understanding their importance will be needed before testing of women in the general population can be undertaken.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [41] Recurrent BRCA1 and BRCA2 Mutations in Mexican Women with Breast Cancer
    Torres-Mejia, Gabriela
    Royer, Robert
    Llacuachaqui, Marcia
    Akbari, Mohammad R.
    Giuliano, Anna R.
    Martinez-Matsushita, Louis
    Angeles-Llerenas, Angelica
    Ortega-Olvera, Carolina
    Ziv, Elad
    Lazcano-Ponce, Eduardo
    Phelan, Catherine M.
    Narod, Steven A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (03) : 498 - 505
  • [42] Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations
    Metcalfe, Kelly A.
    WOMENS HEALTH, 2009, 5 (01) : 63 - 68
  • [43] BRCAsearch - results of population-based screening of BRCA1 and BRCA2 germline mutations in incident breast cancer in South Sweden
    Loman, N.
    Borg, A.
    Henriksson, K.
    Kristoffersson, U.
    Kvist, A.
    Silfverberg, B.
    Toerngren, T.
    Brandberg, Y.
    Nilsson, M.
    CANCER RESEARCH, 2017, 77
  • [44] BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer
    Turchetti, D
    Cortesi, L
    Federico, M
    Bertoni, C
    Mangone, L
    Ferrari, S
    Silingardi, V
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (16) : 2083 - 2089
  • [45] Frequency of pathogenic variants in BRCA1 and BRCA2 genes in a Russian population-based sample and in patients with breast or ovarian cancer
    Limonova, Alena
    Meshkov, Alexey
    Ershova, Alexandra
    Kiseleva, Anna
    Skirko, Olga
    Klimushina, Marina
    Sotnikova, Evgeniia
    Kurilova, Olga
    Efimova, Irina
    Lyubchenko, Ludmila
    Filippova, Margarita
    Poloznikov, Andrey
    Kutsenko, Vladimir
    Pokrovs-Kaya, Maria
    Drapkina, Oxana
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 373 - 373
  • [46] Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
    Yao, Lu
    Sun, Jie
    Zhang, Juan
    He, Yingjian
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 441 - 445
  • [47] BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women
    Gilbert, F
    Dabney, MK
    Diemer, K
    Ludwig, S
    Rosenthal, G
    Osborne, MP
    CANCER: GENETICS AND THE ENVIRONMENT, 1997, 833 : 198 - 203
  • [48] Pregnancy and breast cancer risk in women with BRCA1 or BRCA2 mutations
    Carol Lovegrove
    Nature Clinical Practice Oncology, 2006, 3 (1): : 9 - 9
  • [49] BRCA1 and BRCA2 germline mutations in a population-based series of early onset breast cancer patients in France.
    Sinilnikova, OM
    Bonadona, V
    Chopin, S
    Brémond, A
    Mignotte, H
    Mathevet, P
    Martin, A
    Zinzindohoue, C
    Raudrant, D
    Rudigoz, RC
    Palayer, C
    Romestaing, P
    Montvernay, C
    Lenoir, G
    Lasset, C
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A66 - A66
  • [50] Re:: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients -: Response
    Vahteristo, P
    Syrjäkoski, K
    Eerola, H
    Kainu, T
    Holli, K
    Blomqvist, C
    Kallioniemi, OP
    Nevanlinna, H
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (02) : 153 - 154